Prolonged production of inflammatory mediators derived from arachidonic acid through the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) is responsible for various inflammatory diseases. It was shown that inhibition of any of these pathways could potentiate the other one, so inhibition of both pathways represents a rational approach to the design and development of more effective and safer anti-inflammatory drugs. The aim of this study was synthesis, investigation of enzyme inhibition and redox properties of five N-hydroxyurea and hydroxamic acid derivatives (IND-NHU, FLU-NHU, DIKLO-NHU, IBU-Ac and NAP-Ac), designed as potential dual COX-2 and 5-LOX inhibitors, according to the structure-activity relationship (SAR) analysis of literature data. N-hydroxyurea analogs IND-NHU, FLU-NHU and DIKLO-NHU were synthesized in two steps reactions, while compounds IBU-Ac and NAP-Ac were synthesized in four steps reactions, according to previously published procedures. Effects of various concentrations of synthesized compounds were monitored on oxidative stress parameters (TOS, TAS, PAB and SHG) and calculated oxy scores (OS) had low values, which indicates good antioxidant potency. The ability of compounds to inhibit COX-2 and 5-LOX enzymes was determined using COX-2 and 5-LOX enzyme immunoassay kits. Derivatives FLU-NHU (IC50 = 1.93 µmol), DIKLO-NHU (IC50 = 0.91 µmol), IBU-Ac (IC50 = 1.05 µmol) and NAP-Ac (IC50 = 1.27 µmol) showed comparable 5-LOX inhibitory activity to commercially available 5-LOX inhibitor zileuton (IC50 = 0.61 µmol). Derivative IND-NHU showed significant COX-2 inhibitory activity (IC50 = 10 µmol), while investigation of COX-2 inhibitory activity of remaining compounds is in progress.
Previous Article in event
Next Article in event
Synthesis, evaluation of enzyme inhibition and redox properties of potential dual COX-2 and 5-LOX inhibitors
Published: 01 November 2022 by MDPI in 8th International Electronic Conference on Medicinal Chemistry session Small molecules as drug candidates
https://doi.org/10.3390/ECMC2022-13287 (registering DOI)
Keywords: N-hydroxyurea; hydroxamic acid; COX-2; 5-LOX; synthesis